AKRO - Financial Reports List - Akero Therapeutics, Inc. - IntrinsicAlpha

Akero Therapeutics, Inc. AKRO

Healthcare - Biotechnology - NASDAQ - US

$ 37.67

0.106 %

$ 3 B

Market Cap

-10.05

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-26.89%	-26.11%
Annual Report	FY	10-K	2024-12-31	0.00%	-66.09%	-65.11%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-83.33%	-75.27%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-80.12%	-84.52%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-128.30%	-108.51%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-169.40%	-143.40%
Annual Report	FY	10-K	2023-12-31	0.00%	-39.34%	-50.12%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-13.33%	-29.16%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-13.43%	-29.12%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	10.15%	-10.37%

1